Black Diamond Therapeutics Inc.
BDTX | NASDAQ
$1.94
-$0.01 (-0.51%)
Sep 22, 2026, 12:11 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 70M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 27K | n/a | n/a | 86K | n/a | n/a | n/a | 86K | 86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -27K | n/a | n/a | -86K | 70M | n/a | n/a | -86K | -86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -12.06M | -11.26M | -17.61M | -10.98M | -13.42M | 54.53M | -18.28M | -18.13M | -22.13M | -20.25M | -20.86M | -24.01M | -20.03M | -21.56M | -21.85M | -22.12M | -23.17M | -25.68M | -26.08M | -35.36M | -34.72M | -30.71M |
Interest Income | 922K | 1.02M | 1.18M | 1.16M | 1.12M | 595K | 565K | 516K | 464K | 637K | 324K | 439K | 539K | 622K | 677K | 562K | 386K | 406K | 588K | 776K | 948K | 1.15M |
Pretax Income | -9.91M | -9.04M | -15.12M | -8.5M | -10.56M | 56.54M | -15.99M | -15.56M | -19.91M | -18.23M | -19.41M | -23.01M | -19.15M | -20.88M | -21.08M | -21.65M | -22.93M | -25.51M | -25.87M | -35.08M | -34.35M | -30.3M |
Net Income | -9.91M | -9.04M | -15.12M | -8.5M | -10.56M | 56.54M | -15.99M | -15.56M | -19.91M | -18.23M | -19.41M | -23.01M | -19.15M | -20.88M | -21.08M | -21.65M | -22.93M | -25.51M | -25.87M | -35.08M | -34.35M | -30.3M |
Selling & General & Admin | 4.66M | 4.26M | 3.97M | 3.54M | 4.1M | 4.96M | 5.98M | 5.22M | 9.57M | 6.7M | 5.57M | 7.86M | 6.88M | 6.81M | 7.24M | 6.28M | 6.98M | 7.89M | 6.42M | 7.74M | 8M | 7.89M |
Research & Development | 7.39M | 7M | 6.3M | 7.44M | 9.32M | 10.51M | 12.3M | 12.91M | 12.47M | 13.46M | 15.29M | 16.15M | 13.15M | 14.75M | 14.61M | 15.85M | 16.2M | 17.79M | 19.66M | 27.63M | 26.72M | 22.82M |
Other Expenses | n/a | n/a | 7.35M | n/a | -86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.06M | 11.26M | 17.61M | 10.98M | 13.33M | 15.47M | 18.28M | 18.13M | 22.04M | 20.16M | 20.86M | 24.01M | 20.03M | 21.56M | 21.85M | 22.12M | 23.17M | 25.68M | 26.08M | 35.36M | 34.72M | 30.71M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.06M | 11.26M | 17.61M | 10.98M | 13.42M | 15.47M | 18.28M | 18.13M | 22.13M | 20.25M | 20.86M | 24.01M | 20.03M | 21.56M | 21.85M | 22.12M | 23.17M | 25.68M | 26.08M | 35.36M | 34.72M | 30.71M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 57.37M | 57.23M | 57.09M | 56.65M | 56.8M | 56.66M | 56.61M | 56.51M | 55.16M | 51.81M | 47.45M | 50.94M | 36.52M | 36.48M | 36.39M | 36.35M | 36.29M | 36.27M | 36.23M | 36.22M | 36.18M | 36.12M |
Shares Outstanding (Diluted) | 57.37M | 57.23M | 57.09M | 56.93M | 56.8M | 57.67M | 56.61M | 56.51M | 55.16M | 51.81M | 47.45M | 50.94M | 36.52M | 36.48M | 36.39M | 36.35M | 36.29M | 36.27M | 36.23M | 36.22M | 36.18M | 36.12M |
EPS (Basic) | -0.17 | -0.16 | -0.26 | -0.15 | -0.19 | 1 | -0.28 | -0.28 | -0.36 | -0.35 | -0.41 | -0.45 | -0.52 | -0.57 | -0.59 | -0.60 | -0.63 | -0.70 | -0.71 | -0.97 | -0.95 | -0.84 |
EPS (Diluted) | -0.17 | -0.16 | -0.26 | -0.15 | -0.19 | 0.98 | -0.28 | -0.28 | -0.36 | -0.35 | -0.41 | -0.45 | -0.52 | -0.57 | -0.59 | -0.60 | -0.63 | -0.70 | -0.71 | -0.97 | -0.95 | -0.84 |
EBITDA | -13.26M | -9.01M | -10.2M | -8.41M | -10.48M | 56.63M | -15.9M | -15.47M | -19.82M | -18.14M | -19.32M | -22.89M | -19.04M | -20.75M | -20.95M | -21.53M | -22.8M | -25.38M | -25.74M | -35.03M | -34.33M | -30.69M |
EBIT | -13.29M | -9.04M | -10.26M | -8.5M | -10.56M | 56.54M | -15.99M | -15.56M | -19.91M | -18.23M | -19.41M | -23.01M | -19.15M | -20.88M | -21.08M | -21.65M | -22.93M | -25.51M | -25.87M | -35.08M | -34.35M | -30.71M |
Depreciation & Amortization | 28K | 27K | 66K | 86K | 86K | 87K | 85K | 86K | 86K | 86K | 86K | 115K | 114K | 122K | 126K | 129K | 128K | 125K | 123K | 43K | 20K | 19K |
Add to Watchlist
Select watchlists to add or remove BDTX